✦ LIBER ✦

Therapy of acute myelogenous leukemia

✍ Scribed by Emil J. Freireich; Michael J. Keating; Edmund A. Gehan; Kenneth B. McCredie; Gerald P. Bodey; Terry Smith

Publisher: John Wiley and Sons
Year: 1978
Tongue: English
Weight: 726 KB
Volume: 42
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197808)42:2+<874::aid-cncr2820420709>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Murine and humanized constructs of monoc

Murine and humanized constructs of monoclonal antibody m195 (anti-cd33) for the therapy of acute myelogenous leukemia

✍ Philip C. Caron; Michael A. Schwartz; Man Sung Co; Cary Queen; Ronald D. Finn; M 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 799 KB

Outcome of patients with acute myelogeno

Outcome of patients with acute myelogenous leukemia after second salvage therapy

✍ Francis Giles; Susan O'Brien; Jorge Cortes; Srdan Verstovsek; Carlos Bueso-Ramos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Financial analysis of patients with newl

Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapy

✍ Ellin Berman; Claudia Little; Bonnie Teschendorf; Meaghan Jones; Glenn Heller 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Background: Medicare and third-party payers may be reluctant to pay for investigational (protocol) therapy for patients with cancer on the premise that such treatment is more expensive than standard therapy. however, prior studies that have attempted to compare protocol therapy with standard the

Relationship between patients' age, bone

Relationship between patients' age, bone marrow karyotype, and outcome of induction therapy in acute myelogenous leukemia

✍ Dr. Ph. Bernard; F. Lacombe; J. Reiffers; B. David; G. Marit; M. J. Bourdeau; A. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

Bone marrow karyotypes were performed in 88 cases of adult acute myelogenous leukemia (AML) at diagnosis and classified NN (normal), AA (abnormal), and AN (mixture of normal and abnormal metaphases). A clear relationship was found between karyotype and complete remission (CR) rate: 58% CR in (NN + A

Multivariate analysis of factors associa

Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia

✍ Richard S. Schwartz; F. Roy Mackintosh; Stanley L. Schrier; Peter L. Greenberg 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 861 KB

Prediction of therapy-related acute myel

Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma

✍ Legare, Robert D.; Gribben, John G.; Maragh, Marlon; Hermanowski-Vosatka, Anne; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/ MDS) are being reported with increasing frequency as a complication of ABMT for Hodgkin's disease and non-Hodgkin's lymphoma. At present there is no method available to predict who is at risk or is destined to develop th